Literature DB >> 22569735

Thermosensitive hydrogel of hydrophobically-modified methylcellulose for intravaginal drug delivery.

Ning Li1, Meihua Yu, Liandong Deng, Jun Yang, Anjie Dong.   

Abstract

Hydrogels with the advantages of prolonging drug release and administration convenience are necessary for intravaginal drug delivery to prevent sexual transmission of human immunodeficiency virus and other vaginal infections. In this study, the thermosensitive hydrogel of methylcellulose modified by stearic acid (MCS) were evaluated in the presence of NaCl and phosphates, which exhibited sol-to-gel transition performance at body temperature or even lower. The in vitro cytotoxicity and in vivo mucosal irritation were investigated and the results showed that MCS hydrogel possessed good biocompatibility similar with hydroxyethyl cellulose (HEC) gel. Significantly, the release studies revealed that MCS hydrogel could control tenofovir sustained release for 10 h without burst release, longer than that from HEC gel or poloxamer 407 hydrogel. Therefore, MCS thermosensitive hydrogel would be a promising carrier for intravaginal delivery of antiviral drugs for long time controlled release.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22569735     DOI: 10.1007/s10856-012-4664-9

Source DB:  PubMed          Journal:  J Mater Sci Mater Med        ISSN: 0957-4530            Impact factor:   3.896


  25 in total

Review 1.  An overview of sexually transmitted diseases. Part I.

Authors:  T J Brown; A Yen-Moore; S K Tyring
Journal:  J Am Acad Dermatol       Date:  1999-10       Impact factor: 11.527

2.  Design of a semisolid vaginal microbicide gel by relating composition to properties and performance.

Authors:  Alamelu Mahalingam; Eric Smith; Judit Fabian; Festo R Damian; Jennifer J Peters; Meredith R Clark; David R Friend; David F Katz; Patrick F Kiser
Journal:  Pharm Res       Date:  2010-09-15       Impact factor: 4.200

3.  pH-sensitive Eudragit nanoparticles for mucosal drug delivery.

Authors:  Jin-Wook Yoo; Namita Giri; Chi H Lee
Journal:  Int J Pharm       Date:  2010-10-31       Impact factor: 5.875

Review 4.  Therapeutic AIDS vaccines.

Authors:  A S Bourinbaiar; R S Root-Bernstein; R Abulafia-Lapid; P G Rytik; A N Kanev; V Jirathitikal; V G Orlovsky
Journal:  Curr Pharm Des       Date:  2006       Impact factor: 3.116

Review 5.  Gels as vaginal drug delivery systems.

Authors:  J das Neves; M F Bahia
Journal:  Int J Pharm       Date:  2006-03-17       Impact factor: 5.875

Review 6.  Vaginal drug delivery systems for HIV prevention.

Authors:  Lisa Cencia Rohan; Alexandra B Sassi
Journal:  AAPS J       Date:  2009-02-05       Impact factor: 4.009

Review 7.  Development of topical microbicides to prevent the sexual transmission of HIV.

Authors:  Robert W Buckheit; Karen M Watson; Kathleen M Morrow; Anthony S Ham
Journal:  Antiviral Res       Date:  2009-10-27       Impact factor: 5.970

8.  Controlled release of insulin from PLGA nanoparticles embedded within PVA hydrogels.

Authors:  J Liu; S M Zhang; P P Chen; L Cheng; W Zhou; W X Tang; Z W Chen; C M Ke
Journal:  J Mater Sci Mater Med       Date:  2007-08-01       Impact factor: 3.896

9.  Safety and tolerability of tenofovir vaginal gel in abstinent and sexually active HIV-infected and uninfected women.

Authors:  Kenneth H Mayer; Lisa A Maslankowski; Fang Gai; Wafaa M El-Sadr; Jessica Justman; Antonia Kwiecien; Benoît Mâsse; Susan H Eshleman; Craig Hendrix; Kathleen Morrow; James F Rooney; Lydia Soto-Torres
Journal:  AIDS       Date:  2006-02-28       Impact factor: 4.177

10.  Poverty, gender inequities, and women's risk of human immunodeficiency virus/AIDS.

Authors:  Suneeta Krishnan; Megan S Dunbar; Alexandra M Minnis; Carol A Medlin; Caitlin E Gerdts; Nancy S Padian
Journal:  Ann N Y Acad Sci       Date:  2007-10-22       Impact factor: 6.499

View more
  5 in total

1.  Nanogels of methylcellulose hydrophobized with N-tert-butylacrylamide for ocular drug delivery.

Authors:  Marion Jamard; Todd Hoare; Heather Sheardown
Journal:  Drug Deliv Transl Res       Date:  2016-12       Impact factor: 4.617

2.  3-D culture of human umbilical vein endothelial cells with reversible thermosensitive hydroxybutyl chitosan hydrogel.

Authors:  Ya Nan Wei; Qian Qian Wang; Ting Ting Gao; Ming Kong; Kui Kun Yang; Yi An; Shao Yan Jiang; Jian Li; Xiao Jie Cheng; Xi Guang Chen
Journal:  J Mater Sci Mater Med       Date:  2013-03-24       Impact factor: 3.896

3.  Chitosan and Kappa-Carrageenan Vaginal Acyclovir Formulations for Prevention of Genital Herpes. In Vitro and Ex Vivo Evaluation.

Authors:  María-Pilar Sánchez-Sánchez; Araceli Martín-Illana; Roberto Ruiz-Caro; Paulina Bermejo; María-José Abad; Rubén Carro; Luis-Miguel Bedoya; Aitana Tamayo; Juan Rubio; Anxo Fernández-Ferreiro; Francisco Otero-Espinar; María-Dolores Veiga
Journal:  Mar Drugs       Date:  2015-09-18       Impact factor: 5.118

4.  Nanoparticle Encapsulation for Antiretroviral Pre-Exposure Prophylaxis.

Authors:  Karl Khandalavala; Subhra Mandal; Rachel Pham; Christopher J Destache; Annemarie Shibata
Journal:  J Nanotechnol Mater Sci       Date:  2017-08-07

Review 5.  Nanotechnology-based antiviral therapeutics.

Authors:  Malobika Chakravarty; Amisha Vora
Journal:  Drug Deliv Transl Res       Date:  2021-06       Impact factor: 4.617

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.